Cancer Research Cancer Health Disparities Conference 2009  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishibashi, Y.
Right arrow Articles by Urashima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishibashi, Y.
Right arrow Articles by Urashima, M.
[Cancer Research 63, 5159-5164, August 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Profiling Gene Expression Ratios of Paired Cancerous and Normal Tissue Predicts Relapse of Esophageal Squamous Cell Carcinoma

Yoshio Ishibashi1, Nobuyoshi Hanyu, Koji Nakada, Yutaka Suzuki, Takashi Yamamoto, Katsuhiko Yanaga, Kiyoshi Ohkawa, Noriko Hashimoto, Toshiharu Nakajima, Hirohisa Saito, Masato Matsushima and Mitsuyoshi Urashima1,,2

Department of Surgery [Y. I., N. Han., K. N., Y. S., T. Y., K. Y.], Department of Biochemistry I [K. O.], and Division of Clinical Research and Development [M. M., M. U.], The Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, and National Center for Child Health and Development [N. Has., T. N., H. S.], Setagaya-ku, Tokyo 154-8567, Japan

Esophageal squamous cell carcinoma has heterogeneous clinical outcomes that cannot be predicted well using any existing clinical or molecular prognostic factors. Gene expression profiling may enable more precise prediction of the clinical outcome of these patients. We developed a new approach using gene expression ratios of paired cancerous and normal tissue specimens from the same patient to reduce the effects of variation among individuals. Using oligonucleotide microarrays, we analyzed total RNA expression levels corresponding to 12,600 transcript sequences in 24 paired cancerous and normal tissue operative specimens from 12 patients with esophageal squamous cell carcinoma. Hierarchical clustering analysis using gene expression ratios (cancer:normal) divided the 12 patients into two groups; all 7 patients in the first cluster survived without relapse (median follow-up, 483 days), whereas all 5 patients in the second cluster relapsed (median relapse-free survival time, 280 days; log-rank test, P = 0.006). In contrast, clustering either with cancerous tissue alone or with normal tissue alone did not show significant differences in the outcomes. The expressions of a variety of genes related with cell cycle, gene-repair, apoptosis and chemoradiotherpay resistance were up-regulated in the poor prognostic cluster. These results suggest that ratios of paired gene expression profiles may more efficiently predict relapse-free survival of esophageal squamous cell carcinoma than existing prognostic factors or than gene expression profiling with cancerous tissue alone.




This article has been cited by other articles:


Home page
JCOHome page
R. Luthra, T.-T. Wu, M. G. Luthra, J. Izzo, E. Lopez-Alvarez, L. Zhang, J. Bailey, J. H. Lee, R. Bresalier, A. Rashid, et al.
Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation
J. Clin. Oncol., January 10, 2006; 24(2): 259 - 267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Okamoto, T. Nikaido, K. Ochiai, S. Takakura, M. Saito, Y. Aoki, N. Ishii, N. Yanaihara, K. Yamada, O. Takikawa, et al.
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
Clin. Cancer Res., August 15, 2005; 11(16): 6030 - 6039.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Dai, L. van't Veer, J. Lamb, Y. D. He, M. Mao, B. M. Fine, R. Bernards, M. van de Vijver, P. Deutsch, A. Sachs, et al.
A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients
Cancer Res., May 15, 2005; 65(10): 4059 - 4066.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I P Hall
Expression profiling: fishing and chips
Gut, July 1, 2004; 53(7): 917 - 918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.